MAIA Biotechnology Stock Forecast - Simple Moving Average
| MAIA Stock | USD 2.61 0.05 1.95% |
MAIA Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast MAIA Biotechnology stock prices and determine the direction of MAIA Biotechnology's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of MAIA Biotechnology's historical fundamentals, such as revenue growth or operating cash flow patterns.
The RSI of MAIA Biotechnology's share price is above 70 at this time. This indicates that the stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are buying or selling MAIA, making its price go up or down. Momentum 73
Buy Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (0.13) | EPS Estimate Current Year (0.74) | EPS Estimate Next Year (0.69) | Wall Street Target Price 12.135 | EPS Estimate Current Quarter (0.19) |
Using MAIA Biotechnology hype-based prediction, you can estimate the value of MAIA Biotechnology from the perspective of MAIA Biotechnology response to recently generated media hype and the effects of current headlines on its competitors.
MAIA Relative Strength Index
The Simple Moving Average forecasted value of MAIA Biotechnology on the next trading day is expected to be 2.61 with a mean absolute deviation of 0.09 and the sum of the absolute errors of 5.56.MAIA Biotechnology Hype to Price Pattern
Investor biases related to MAIA Biotechnology's public news can be used to forecast risks associated with an investment in MAIA. The trend in average sentiment can be used to explain how an investor holding MAIA can time the market purely based on public headlines and social activities around MAIA Biotechnology. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of MAIA Biotechnology's market sentiment to its price can help taders to make decisions based on the overall investors consensus about MAIA Biotechnology.
The Simple Moving Average forecasted value of MAIA Biotechnology on the next trading day is expected to be 2.61 with a mean absolute deviation of 0.09 and the sum of the absolute errors of 5.56. MAIA Biotechnology after-hype prediction price | USD 2.53 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of MAIA Biotechnology to cross-verify your projections. MAIA Biotechnology Additional Predictive Modules
Most predictive techniques to examine MAIA price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for MAIA using various technical indicators. When you analyze MAIA charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
MAIA Biotechnology Simple Moving Average Price Forecast For the 27th of January
Given 90 days horizon, the Simple Moving Average forecasted value of MAIA Biotechnology on the next trading day is expected to be 2.61 with a mean absolute deviation of 0.09, mean absolute percentage error of 0.02, and the sum of the absolute errors of 5.56.Please note that although there have been many attempts to predict MAIA Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that MAIA Biotechnology's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
MAIA Biotechnology Stock Forecast Pattern
| Backtest MAIA Biotechnology | MAIA Biotechnology Price Prediction | Buy or Sell Advice |
MAIA Biotechnology Forecasted Value
In the context of forecasting MAIA Biotechnology's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. MAIA Biotechnology's downside and upside margins for the forecasting period are 0.03 and 9.82, respectively. We have considered MAIA Biotechnology's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of MAIA Biotechnology stock data series using in forecasting. Note that when a statistical model is used to represent MAIA Biotechnology stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 110.3557 |
| Bias | Arithmetic mean of the errors | -0.0331 |
| MAD | Mean absolute deviation | 0.0943 |
| MAPE | Mean absolute percentage error | 0.0645 |
| SAE | Sum of the absolute errors | 5.565 |
Predictive Modules for MAIA Biotechnology
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as MAIA Biotechnology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.MAIA Biotechnology After-Hype Price Density Analysis
As far as predicting the price of MAIA Biotechnology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in MAIA Biotechnology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of MAIA Biotechnology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
MAIA Biotechnology Estimiated After-Hype Price Volatility
In the context of predicting MAIA Biotechnology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on MAIA Biotechnology's historical news coverage. MAIA Biotechnology's after-hype downside and upside margins for the prediction period are 0.13 and 9.74, respectively. We have considered MAIA Biotechnology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
MAIA Biotechnology is risky at this time. Analysis and calculation of next after-hype price of MAIA Biotechnology is based on 3 months time horizon.
MAIA Biotechnology Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as MAIA Biotechnology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading MAIA Biotechnology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with MAIA Biotechnology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.26 | 7.21 | 0.08 | 0.10 | 10 Events / Month | 7 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
2.61 | 2.53 | 3.07 |
|
MAIA Biotechnology Hype Timeline
MAIA Biotechnology is now traded for 2.61. The entity has historical hype elasticity of -0.08, and average elasticity to hype of competition of 0.1. MAIA is forecasted to decline in value after the next headline, with the price expected to drop to 2.53. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -3.07%, whereas the daily expected return is now at 1.26%. The volatility of related hype on MAIA Biotechnology is about 9363.64%, with the expected price after the next announcement by competition of 2.71. About 20.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.74. MAIA Biotechnology had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 10 days. Check out Historical Fundamental Analysis of MAIA Biotechnology to cross-verify your projections.MAIA Biotechnology Related Hype Analysis
Having access to credible news sources related to MAIA Biotechnology's direct competition is more important than ever and may enhance your ability to predict MAIA Biotechnology's future price movements. Getting to know how MAIA Biotechnology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how MAIA Biotechnology may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ELUT | Elutia Inc | 0.04 | 6 per month | 4.92 | 0.03 | 9.52 | (7.27) | 32.08 | |
| LTRN | Lantern Pharma | 0.02 | 4 per month | 0.00 | (0.05) | 10.27 | (5.57) | 23.91 | |
| BCAB | Bioatla | 0.13 | 8 per month | 0.00 | (0.06) | 15.28 | (16.25) | 54.11 | |
| PYPD | PolyPid | (0.07) | 10 per month | 1.40 | 0.23 | 4.79 | (2.58) | 13.34 | |
| RNXT | RenovoRx | 0.01 | 9 per month | 0.00 | (0.03) | 9.90 | (6.54) | 32.58 | |
| ANVS | Annovis Bio | 0.30 | 9 per month | 5.34 | 0.10 | 14.79 | (9.57) | 41.06 | |
| VERU | Veru Inc | 0.04 | 10 per month | 0.00 | (0.15) | 6.07 | (8.61) | 16.36 | |
| TVRD | Tvardi Therapeutics | 0.22 | 11 per month | 0.00 | (0.12) | 5.59 | (5.95) | 15.82 | |
| CELU | Celularity | 0.02 | 6 per month | 0.00 | (0.12) | 9.01 | (8.97) | 26.97 | |
| CALC | CalciMedica Common Stock | 0.06 | 5 per month | 3.73 | 0.13 | 12.74 | (7.12) | 40.42 |
Other Forecasting Options for MAIA Biotechnology
For every potential investor in MAIA, whether a beginner or expert, MAIA Biotechnology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. MAIA Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in MAIA. Basic forecasting techniques help filter out the noise by identifying MAIA Biotechnology's price trends.MAIA Biotechnology Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MAIA Biotechnology stock to make a market-neutral strategy. Peer analysis of MAIA Biotechnology could also be used in its relative valuation, which is a method of valuing MAIA Biotechnology by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
MAIA Biotechnology Market Strength Events
Market strength indicators help investors to evaluate how MAIA Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading MAIA Biotechnology shares will generate the highest return on investment. By undertsting and applying MAIA Biotechnology stock market strength indicators, traders can identify MAIA Biotechnology entry and exit signals to maximize returns.
MAIA Biotechnology Risk Indicators
The analysis of MAIA Biotechnology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in MAIA Biotechnology's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting maia stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.41 | |||
| Semi Deviation | 5.63 | |||
| Standard Deviation | 7.13 | |||
| Variance | 50.78 | |||
| Downside Variance | 39.3 | |||
| Semi Variance | 31.72 | |||
| Expected Short fall | (6.19) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for MAIA Biotechnology
The number of cover stories for MAIA Biotechnology depends on current market conditions and MAIA Biotechnology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that MAIA Biotechnology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about MAIA Biotechnology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
MAIA Biotechnology Short Properties
MAIA Biotechnology's future price predictability will typically decrease when MAIA Biotechnology's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of MAIA Biotechnology often depends not only on the future outlook of the potential MAIA Biotechnology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MAIA Biotechnology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 22.2 M | |
| Cash And Short Term Investments | 9.6 M | |
| Shares Float | 32.1 M |
Check out Historical Fundamental Analysis of MAIA Biotechnology to cross-verify your projections. For information on how to trade MAIA Stock refer to our How to Trade MAIA Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MAIA Biotechnology. If investors know MAIA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MAIA Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of MAIA Biotechnology is measured differently than its book value, which is the value of MAIA that is recorded on the company's balance sheet. Investors also form their own opinion of MAIA Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is MAIA Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MAIA Biotechnology's market value can be influenced by many factors that don't directly affect MAIA Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MAIA Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if MAIA Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MAIA Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.